Tower Research Capital (TRC)’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243 | Sell |
|
|||||
|
2025
Q1 | $5.74K | Buy |
|
|||||
|
2024
Q4 | $387 | Buy |
|
|||||
|
2024
Q3 | $133 | Sell |
|
|||||
|
2024
Q2 | $199 | Sell |
|
|||||
|
2024
Q1 | $690 | Sell |
|
|||||
|
2023
Q4 | $10K | Buy |
|
|||||
|
2023
Q3 | $238 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $286K | Sell |
|
|||||
|
2022
Q2 | $471K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $162K | Buy |
|
|||||
|
2021
Q3 | $45K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $517K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $957K | Sell |
|
|||||
|
2019
Q3 | $1.17M | Buy |
|
|||||
|
2019
Q2 | $410K | Sell |
|
|||||
|
2019
Q1 | $751K | Sell |
|
|||||
|
2018
Q4 | $1.36M | Buy |
|
|||||
|
2018
Q3 | $359K | Sell |
|
|||||
|
2018
Q2 | $840K | Sell |
|
|||||
|
2018
Q1 | $1.96M | Buy |
|
|||||
|
2017
Q4 | $1.94M | Buy |
|
|||||
|
2017
Q3 | $20K | Sell |
|
|||||
|
2017
Q2 | $1.61M | Buy |
|
|||||
|
2017
Q1 | $1.38M | Buy |
|
|||||
|
2016
Q4 | $1.17M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $986K | Sell |
|
|||||
|
2016
Q1 | $1.03M | Buy |
|
|||||
|
2015
Q4 | $227K | Sell |
|
|||||
|
2015
Q3 | $1.22M | Sell |
|
|||||
|
2015
Q2 | $3.06M | Sell |
|
|||||
|
2015
Q1 | $5.72M | Buy |
|
|||||
|
2014
Q4 | $2.33M | Buy |
|
|||||
|
2014
Q3 | $1.28M | Buy |
|
|||||
|
2014
Q2 | $459K | Sell |
|
|||||
|
2014
Q1 | $3.41M | Buy |
|
|||||
|
2013
Q4 | $3.19M | Buy |
|